ReviewCurrent pharmaceutical design2008
Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise.
M P Bernard et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this paperpooled itcites it